Acute Myeloid Leukemia

37 competing products in clinical development for Acute Myeloid Leukemia.

Pipeline by Phase

Pre-clinical1

Phase 117

Phase 1/26

Phase 27

Phase 36

All Products (37)

Product	Company	Stage	Status	Hype
Gilteritinib + Midostaurin	Astellas Pharma	Phase 3	Active	44
Quizartinib High Dose + Quizartinib Low Dose	Daiichi Sankyo	Phase 2	Recruiting	42
gemtuzumab ozogamycin	Chugai Pharmaceutical	Phase 3	Completed	40
Chemotherapy + Quizartinib + Placebo	Daiichi Sankyo	Phase 3	Completed	40
gilteritinib + Placebo	Astellas Pharma	Phase 3	Completed	40
Cytarabine or Supportive Care + Dacogen (decitabine) only	Eisai	Phase 3	Completed	40
Decitabine + Quizartinib + Venetoclax	Daiichi Sankyo	Phase 1/2	Recruiting	39
Gilteritinib + Midostaurin + Daunorubicin + Cytarabine	Astellas Pharma	Phase 2	Active	39
Quizartinib + Fludarabine + Cytarabine + Intrathecal (IT) triple chemotherapy prophylaxis + Etoposide	Daiichi Sankyo	Phase 1/2	Active	36
Compound AC220	Daiichi Sankyo	Phase 2	Completed	35
Quizartinib + Placebo oral tablet + Cytarabine + Idarubicin	Daiichi Sankyo	Phase 2	Completed	35
E7820	Eisai	Phase 2	Completed	35
Decitabine	Eisai	Phase 2	Completed	35
Clofarabine + Cytarabine + Decitabine	Eisai	Phase 2	Completed	35
Quizartinib + Treatment according to Physician's Choice + Standard of Care Chemotherapy	Daiichi Sankyo	Phase 3	Withdrawn	32
PLX3397 + PLX3397	Daiichi Sankyo	Phase 1/2	Completed	32
Gilteritinib + Idarubicin + Cytarabine	Astellas Pharma	Phase 1/2	Completed	32
Gilteritinib + Voriconazole + Midazolam + Cephalexin	Astellas Pharma	Phase 1/2	Completed	32
Milademetan	Daiichi Sankyo	Phase 1	Completed	29
Quizartinib + Cytarabine + Idarubicin + Daunorubicin	Daiichi Sankyo	Phase 1	Completed	29
AC220	Daiichi Sankyo	Phase 1	Completed	29
Gilteritinib + Idarubicin + Cytarabine + Daunorubicin	Astellas Pharma	Phase 1	Completed	29
Decitabine (Dacogen)	Eisai	Phase 1	Completed	29
decitabine	Eisai	Phase 1	Completed	29
Quizartinib + Fludarabine + Cytarabine + Idarubicin + glycosylated G-CSF	Daiichi Sankyo	Phase 1/2	UNKNOWN	28
PRGN-3006 T Cells	Precigen	Phase 1	Active	27
VIP943 (QW) + VIP943 (BIW)	Vincerx Pharma	Phase 1	Recruiting	26
Gilteritinib	Astellas Pharma	Pre-clinical	Completed	26
Tomivosertib	eFFECTOR Therapeutics	Phase 1	Active	23
Quizartinib + Milademetan + Milademetan	Daiichi Sankyo	Phase 1	Terminated	21
Gilteritinib 40 MG Oral Tablet + Cladribine + Cytarabine + Filgrastim + Mitoxantrone	Astellas Pharma	Phase 1	Withdrawn	21
AGS67E	Astellas Pharma	Phase 1	Terminated	21
ASP1235	Astellas Pharma	Phase 1	Terminated	21
KHK2823	Kyowa Kirin	Phase 1	Terminated	21
ZN-d5	Zentalis Pharmaceuticals	Phase 1	Completed	19
Bisantrene Dihydrochloride (high dose) + Bisantrene Dihydrochloride (low dose) + Cytarabine Hydrochloride + Decitabine and cedazuridine	Race Oncology	Phase 1	Withdrawn	15
AFM28	Affimed	Phase 1	Terminated	11